- Home
- GNL vs RXRX Comparison
GNL vs RXRX Comparison
Compare GNL & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNL | RXRX |
|---|---|---|
| Founded | 2011 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2011 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GNL | RXRX |
|---|---|---|
| Price | $8.28 | $4.10 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $10.14 | $7.22 |
| AVG Volume (30 Days) | 1.8M | ★ 16.5M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | ★ 9.20% | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $495,286,000.00 | $74,681,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.98 | $34.96 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $7.48 | $2.77 |
| 52 Week High | $10.04 | $7.18 |
Technical Indicators
Market Signals| Indicator | GNL | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 16.25 | 63.19 |
| Support Level | N/A | $4.05 |
| Resistance Level | $9.63 | $5.12 |
| Average True Range (ATR) | 0.14 | 0.24 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 0.00 | 95.50 |
Price Performance
Historical ComparisonAbout GNL Global Net Lease Inc.
Global Net Lease Inc is a real estate investment trust that manages a globally diversified portfolio of commercial real estate properties. The company is engaged in the ownership, management, operation, lease, acquisition, investment, and sale of the portfolio assets. Its segments include Industrial & Distribution, Retail, and Office. The company derives maximum revenue from the Industrial and Distribution segment. The company geographically operates in the United States, the United Kingdom, Canada, and Europe.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.